Old Web
English
Sign In
Acemap
>
authorDetail
>
Karan Malik
Karan Malik
Harvard University
Medicine
Cancer research
Trk receptor
Pathology
highly selective
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1
2020
Matthew L. Hemming
Michael J. Nathenson
Jia-Ren Lin
Shaolin Mei
Ziming Du
Karan Malik
Adrián Mariño-Enríquez
Jyothi P. Jagannathan
Peter K. Sorger
Monica M. Bertagnolli
Ewa Sicinska
George D. Demetri
Sandro Santagata
Show All
Source
Cite
Save
Citations (12)
Molecular characterization and management of secondary resistance to serial TRK inhibitors.
2019
Journal of Clinical Oncology
Michael J. Nathenson
Matthew L. Hemming
Karan Malik
Jia-Ren Lin
Sandro Santagata
Ziming Du
Adrián Mariño-Enríquez
Timothy Hagan
Otari Chipashvili
Katherine Anne Thornton
Chandrajit P. Raut
Barrett H. Childs
Monica M. Bertagnolli
Ewa Sicinska
Nora Ku
George D. Demetri
Show All
Source
Cite
Save
Citations (1)
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
2019
Journal for ImmunoTherapy of Cancer
Jocelyn Joseph
Michael J. Nathenson
Van Anh Trinh
Karan Malik
Erica N. Nowell
Kristen Carter
Shiao-Pei Weathers
George D. Demetri
Dejka M. Araujo
Anthony Paul Conley
Show All
Source
Cite
Save
Citations (4)
1